1. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis.
- Author
-
Granziera, Cristina, Wuerfel, Jens, Barkhof, Frederik, Calabrese, Massimiliano, Stefano, Nicola De, Enzinger, Christian, Evangelou, Nikos, Filippi, Massimo, Geurts, Jeroen J G, Reich, Daniel S, Rocca, Maria A, Ropele, Stefan, Rovira, Àlex, Sati, Pascal, Toosy, Ahmed T, Vrenken, Hugo, Wheeler-Kingshott, Claudia A M Gandini, Kappos, Ludwig, Group, the MAGNIMS Study, and De Stefano, Nicola
- Subjects
- *
MAGNETIC resonance imaging , *MULTIPLE sclerosis , *DIFFUSION magnetic resonance imaging , *MAGNETIZATION transfer , *MEDICAL research , *BRAIN , *SPINAL cord , *RESEARCH , *RESEARCH methodology , *MEDICAL cooperation , *EVALUATION research , *COMPARATIVE studies , *RESEARCH funding , *NEURORADIOLOGY - Abstract
Quantitative MRI provides biophysical measures of the microstructural integrity of the CNS, which can be compared across CNS regions, patients, and centres. In patients with multiple sclerosis, quantitative MRI techniques such as relaxometry, myelin imaging, magnetization transfer, diffusion MRI, quantitative susceptibility mapping, and perfusion MRI, complement conventional MRI techniques by providing insight into disease mechanisms. These include: (i) presence and extent of diffuse damage in CNS tissue outside lesions (normal-appearing tissue); (ii) heterogeneity of damage and repair in focal lesions; and (iii) specific damage to CNS tissue components. This review summarizes recent technical advances in quantitative MRI, existing pathological validation of quantitative MRI techniques, and emerging applications of quantitative MRI to patients with multiple sclerosis in both research and clinical settings. The current level of clinical maturity of each quantitative MRI technique, especially regarding its integration into clinical routine, is discussed. We aim to provide a better understanding of how quantitative MRI may help clinical practice by improving stratification of patients with multiple sclerosis, and assessment of disease progression, and evaluation of treatment response. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF